Loading...
•
Mar 31, 2022
Insulet Q1 2022 Earnings Report
Insulet reported a strong start to 2022 with first quarter revenue increasing by 17% year-over-year, driven by global Omnipod adoption and the commercial launch of Omnipod 5.
Key Takeaways
Insulet Corporation reported a 17.1% increase in revenue for the first quarter of 2022, reaching $295.4 million. The growth was driven by strong global Omnipod adoption and the ongoing commercial launch of the Omnipod 5 Automated Insulin Delivery System. The company's financial results exceeded guidance, with a gross margin of 71.0% and operating income of $37.9 million.
First quarter revenue increased by 17.1% year-over-year to $295.4 million.
Total Omnipod revenue increased by 15.6% to $269.5 million.
U.S. Omnipod revenue increased by 21.5% to $174.1 million.
The company reaffirmed its expected revenue growth of 12% to 16% for the year ending December 31, 2022.
Insulet
Insulet
Insulet Revenue by Segment
Revenue by Segment
U.S. Omnipod Revenue
CapyFin.comInternational Omnipod Revenue
CapyFin.comDrug Delivery Revenue
CapyFin.com Forward Guidance
Insulet expects revenue growth of 12% to 15% for the quarter ending June 30, 2022. For the year ending December 31, 2022, the Company is reaffirming its expected revenue growth of 12% to 16%.
Positive Outlook
- Total Omnipod revenue is expected to grow 17% to 20%.
- U.S. Omnipod revenue is expected to grow 21% to 24%.
- The company reaffirmed its expected revenue growth of 12% to 16% for the year ending December 31, 2022.
- Total Omnipod revenue is expected to grow 16% to 20% for the year ending December 31, 2022.
- U.S. Omnipod revenue is expected to grow 19% to 23% for the year ending December 31, 2022.
Challenges Ahead
- Drug Delivery revenue is expected to decline 43% to 37%.
- International Omnipod revenue is expected to grow 9% to 12%.
- Operating margin is expected to be flat year-over-year.
- Drug Delivery revenue is expected to decline 35% to 30% for the year ending December 31, 2022.
- International Omnipod revenue is expected to grow 9% to 14% for the year ending December 31, 2022.
Revenue & Expenses
Visualization of income flow from segment revenue to net income